sftd
Doribax (doripenem injection), FDA-Approved for Complicated Urinary Tract and Intra-abdominal Infections
Filed in archive Bacteria and Bacterial Infections , FDA Approvals , Treatment by Gloria Gamat on October 18, 2007
Currently, the prescribed medication for the treatment of complicated urinary tract infections is levofloxacin while meropenem for complicated intra-abdominal infections.

7769840.jpg


Found to have a cure rate comparable to levofloxacin and meropenem and have been shown to be active against several strains of bacteria - Doribax (doripenem injection, 500 mg intravenous infusion) - has recently approved by the FDA for the treatment of complicated urinary tract infections and intra-abdominal infections.

Doribax is a product of Johnson and Johnson Pharmaceutical Research and Development, LLC.

Find more details from FDA News and J&J Press Release.



Permalink: Doribax (doripenem injection), FDA-Approved for Complicated Urinary Tract and Intra-abdominal Infections
Tags: Doribax  doripenem  injection  500  mg  intravenous  infusion  urinary  tract  infections  intraabdominal  infe 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/97500
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Doribax (doripenem injection), FDA-Approved for Complicated Urinary Tract and Intra-abdominal Infections:

  • Currently 8.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.00 out of 4 vote(s) cast.
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!